The company produces a wide range of pharmaceuticals, ranging from Alfusosin to Zolpidem. It also produces a good number of OTC, or Over-The-Counter drugs, such as Gold Bond, Allegra Icy-hot and Selsun Blue used by millions of consumers around the globe. The above products became available when Sanofi acquired the Chattem Company in 2010.
In January 2012, Sanofi-Synthelabo relocated to 54 rue La Boetie, which is located within the 8th arrondissement of Paris, from its original headquarters at the 13th arrondissement of Paris, which was 174 Avenue de France.
In addition in producing pharmaceuticals, Sanofi-Synthelabo is also involved in collaborative research projects, such as the non-chemical safety organisation known as the InnoMed PredTox. They also have various academic partners, such as when in June 2010, they partnered with Charite University of Berlin to sign a cooperation agreement for the research of medicine and therapies.
So, as can be seen, the above pharmaceutical company has indeed a very diverse and rich company background. it has produced well-known, highly-respected medications that are extensively used all around the world every day.
Sanofi-Synthelabo-A company that stands alone in its uniqueness and its professionalism. It is a company that has weathered the storms of change and has stood the test of time.